QUAD by MEDVi Review
4-in-1 sublingual ED liquid combining four prescription mechanisms in a single rapid-absorb dose.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
Quick Verdict
The most differentiated ED product on this site. If you've tried the standard pills and want something with a faster onset and a broader pharmacological profile, QUAD is worth a clinician consultation. The $12/dose price is competitive for a prescription product.
- 4-in-1 formula covers multiple ED mechanisms in one dose
- Sublingual absorption: faster onset than oral tablets
- No monthly subscription: pay per dose
- Clinician-prescribed with MEDVi's established telehealth infrastructure
- Contains apomorphine, not suitable for all patients (contraindicated with nitrates)
- Newer product with limited long-term outcome data
- ED-only, no broader men's health coverage
QUAD by MEDVi Pricing
Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at QUAD by MEDVi.
| Program / Membership Fee | No subscription required |
| Medication Cost (From) | From $12 – $199/mo |
QUAD is priced per dose at $12, with no monthly subscription required. The sublingual liquid dissolves under the tongue, bypassing the digestive system for faster absorption than standard oral ED pills.
Who QUAD by MEDVi Is For
QUAD is the right choice for men who have tried standard sildenafil or tadalafil and want a faster-acting alternative, or who want to try a multi-mechanism approach. The sublingual format bypasses the stomach for quicker onset. Not suitable for men on nitrates or with certain cardiovascular conditions: clinician review required.
Men who have tried standard ED medications and want a faster-acting, multi-mechanism alternative.
Signature Programs
- ›QUAD 4-in-1 sublingual liquid (Sildenafil + Tadalafil + Vardenafil + Apomorphine)
Medication Formulary
How QUAD by MEDVi Scores
QUAD by MEDVi scores 4.3 / 5 overall (cost 4.5, experience 4.2, trust 4.3), which makes it one of the strong mid-tier options in the erectile dysfunction category we cover.
See how QUAD by MEDVi compares in our full erectile dysfunction rankings, or read the Best ED Treatments You Can Get Online in 2026 guide. Our methodology explains how we score each provider.
Frequently Asked Questions
How much does QUAD by MEDVi cost per month?
QUAD by MEDVi's published pricing runs $12 to $199 per month. QUAD is priced per dose at $12, with no monthly subscription required. The sublingual liquid dissolves under the tongue, bypassing the digestive system for faster absorption than standard oral ED pills. Confirm the all-in monthly total at checkout, because telehealth pricing changes without notice.
Does QUAD by MEDVi require a monthly membership?
No. QUAD by MEDVi does not require a recurring membership. Your cost depends on the consultation, prescription, and fulfillment option you choose.
What medications does QUAD by MEDVi prescribe?
QUAD by MEDVi lists sildenafil, tadalafil, vardenafil, among others. What you are prescribed depends on the clinician's assessment and your state.
Is QUAD by MEDVi legit?
QUAD by MEDVi connects patients with licensed clinicians for erectile dysfunction care. At our last check it held a 4.3/5 Trustpilot rating from 14,616 reviews. We score its trust and transparency at 4.3/5. Before ordering, check that the clinician is licensed in your state and, for compounded drugs, which pharmacy fills the prescription.
Can I cancel QUAD by MEDVi anytime?
Most telehealth plans, QUAD by MEDVi's included, are cancelled through the patient portal or support team, but refund terms vary. Read the current terms before your first refill date to avoid an unwanted renewal.
- Goldstein et al., NEJM 1998 (Sildenafil) · Pivotal NEJM trial establishing sildenafil efficacy: 69% of attempts successful vs 22% placebo.
- Brock et al., J Urol 2002 (Tadalafil) · Tadalafil 20 mg showed 75% successful intercourse attempts vs 32% placebo in pivotal Phase III trial.
- Bhasin et al., J Clin Endocrinol Metab 2018 (Endocrine Society TRT guideline) · Endocrine Society clinical practice guideline recommends testosterone therapy for men with symptomatic hypogonadism confirmed by low serum testosterone on two morning measurements.
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.